Childhood Burkitt Lymphoma [clinicaltrials_resource:0b9fd850370e0856215b7273bdc82055]
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer [clinicaltrials:NCT00006251]Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT00014235]Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies [clinicaltrials:NCT00040846]clinicaltrials:NCT00049504clinicaltrials:NCT00057811Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [clinicaltrials:NCT00058461]Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [clinicaltrials:NCT00078858]Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [clinicaltrials:NCT00101205]Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00101270]Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00105001]Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [clinicaltrials:NCT00112593]Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00118352]Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [clinicaltrials:NCT00217412]A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [clinicaltrials:NCT00343798]Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma [clinicaltrials:NCT00363272]Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma [clinicaltrials:NCT00458731]High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors [clinicaltrials:NCT00536601]Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [clinicaltrials:NCT00867529]Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [clinicaltrials:NCT00933985]Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma [clinicaltrials:NCT00994500]Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant [clinicaltrials:NCT01231412]MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia [clinicaltrials:NCT01231919]Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant [clinicaltrials:NCT01251575]Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [clinicaltrials:NCT01427881]Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients [clinicaltrials:NCT01623856]MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [clinicaltrials:NCT01748721]clinicaltrials:NCT01760655Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas [clinicaltrials:NCT01793233]Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT01839916]Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant [clinicaltrials:NCT01959477]
condition [clinicaltrials_vocabulary:condition]
Childhood Burkitt Lymphoma [clinicaltrials_resource:0b9fd850370e0856215b7273bdc82055]
Bio2RDF identifier
0b9fd850370e0856215b7273bdc82055
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0b9fd850370e0856215b7273bdc82055
identifier
clinicaltrials_resource:0b9fd850370e0856215b7273bdc82055
title
Childhood Burkitt Lymphoma
@en
label
Childhood Burkitt Lymphoma [clinicaltrials_resource:0b9fd850370e0856215b7273bdc82055]
@en